Advertisement

Topics

Companies Related to "Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation" [Most Relevant Company Matches] RSS

13:47 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation" found in our extensive corporate database of over 50,000 company records.

Showing "Assessment Biomarkers Recurrent Infection Post liver Transplantation" Companies 1–25 of 1,400+

Relevant

Vesta Therapeutics, Inc

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, huma...


Rebiotix Inc.

Rebiotix Inc, which is part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionize the treatment of debilitating diseases. Rebiotix possesses a deep and diverse clinical pipeline, with its lead drug candidate, RBX2660, in Phase 3 clinical development for th...

TcLand S.A.

Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmaceutical company, pioneer in personalised medicine in transplantation and auto-immune diseases. Originally specialised in analysis and monitoring of T cell immune responses, the company develops now sp...


American Liver Foundation

The American Liver Foundation is the nation’s largest non-profit organization focused solely on promoting liver health and disease prevention. The mission of the American Liver Foundation is to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Sirion Therapeutics, Inc.

Herpetic Keratitis is the number one infectious cause of corneal blindness in the U.S. Herpes simplex virus infections are very common, with nearly 60% of the US population showing evidence of infection by age five. Approximately 1% of infected patients develop ocular outbreaks, with 20,000 primary cases of ocular herpes diagnosed in the US each year. After the primary infection, ocular HSV typic...

Ambys Medicines

Ambys Medicines is a biotechnology company focused on discovering and developing transformative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet th...

Oncimmune (USA) LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

Oncimmune LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

Banyan Biomarkers, Inc.

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focused on developing a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and improve the medical management of head i...

Cleveland HeartLab Inc.

Cleveland HeartLab Inc. is a clinical laboratory and disease management company spun out of Cleveland Clinic in 2009. It offers a robust menu of propriety diagnostic tests for the assessment of cardiovascular disease risk that are based on high value molecular biomarkers. CHL operates a CLIA-certified and CAP-accredited clinical laboratory that provides ph...

Jewish Hospital and University of Louisville

Jewish Hospital, a part of KentuckyOne Health, is an internationally renowned high-tech tertiary referral center developing leading-edge advancements in hand and microsurgery, heart and lung care, home care, cancer care, rehab medicine, sports medicine, orthopaedics, neuroscience, occupational health, organ transplantation and outpatient and primary...

The Washington Post

The Washington Post provides award-winning news and understanding about the politics, policies, personalities and institutions that make Washington, D.C. the world's seat of power, and is a critical tool and information source for those who call Washington, D.C. home. In digital form, The Washington Post combines its world-class journalism with the latest ...

YES

YES is a grassroots organization that provides cancer patients with support, resources, options, education and hope in their fight against liver tumors. It is made up of survivors who have undergone treatment for primary hepatocellular (liver) cancer or liver metastases (cancer that has spread to the liver) from other cancers. For more information ...

American Society of Transplantation (AST)

The American Society of Transplantation (AST) is an international organization of transplant professionals who are dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation. The Society comprises more than 3,100 transplant physicians, surgeons, scientists and allied health ...

National Institute of Transplantation

The National Institute of Transplantation is an internationally recognized leader in all scientific areas of organ transplantation including laboratory and clinical research as well as professional and public education. The institute was founded by Robert Mendez MD, FACS and Rafael G. Mendez MD, FACS with the generous support of The Daughters of Charity at St. Vincent Medical Center, west of downt...

American Society of Transplantation

The American Society of Transplantation (AST) is an international organization of transplant professionals who are dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation. The Society comprises more than 3,300 transplant physicians, surgeons, scientists and allied health ...

Bioenvision

We are a product-oriented biopharmaceutical company primarily focused upon the acquisition, development and marketing of compounds and technologies for the treatment of cancer, autoimmune disease and infection. Our product pipeline includes Evoltra® (Clofarabine), Modrenal® (for which Bioenvision has obtained regulatory approval for marketing in the United Kingdom for the treatment of post-meno...

AlphaNet, Inc.

Alpha-1 Antitrypsin Deficiency is one of North America’s most prevalent, potentially lethal hereditary disorders. Discovered in 1963, Alpha-1 can cause life-threatening lung and/or liver disease. It is a leading genetic killer of adults in North America and a leading cause of liver transplants in children. It is estimated that between 10,000 and 15,000 ...

Echosens

Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan® is supported by over 2,000 peer reviewed publications. http://www.echosens.us/

Amplion Inc.

Amplion publishes BiomarkerBase™ (http://www.biomarkerbase.com), the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every biomarker used in and FDA-approved test or drug label, and thousands of biomarkers being used and developed in clinical trials. Many of the world’s leading diagnostics and bi...

Viamet Pharmaceuticals Inc.

Viamet is a biopharmaceutical company focused on the discovery, development and commercialization of novel antifungal agents based on its proprietary metalloenzyme medicinal chemistry platform, the Metallophile® Technology. Metalloenzymes are enzymes that contain a metal, such as iron, zinc or copper, which is linked to the enzyme’s protein compone...

Vivomicx

We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Validate: the pharmacological identity of your NME in complex tissues in vivo, before your drug enters clinical testing the expression of your new putative targets in patient materials your biomarkers...

Exten Industries Incorporated

Exten Industries, through its subsidiaries, is dedicated to providing solutions to the medical community for some of its most pressing needs. These include better treatment options for chronic liver disease, better research tools for the pharmaceutical industry, complex plasma proteins for chronic and acute therapies, and stem cells for cellular transplantation. We believe our patents and propriet...

GNS Healthcare and Global Genomics Group

G3 is a global leader in pan-omics and investigates biological networks that lead to the development of disease to identify novel biomarkers and therapeutic targets. G3 combines precision phenotyping with pan-omics (genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics and lipoprotein proteomics) and systems-biology driven bioinforma...

Texas Children's Hospital

Texas Children's Hospital runs an active transplantation program in heart, lungs, liver, kidney and bone morrow for pediatric patients. In 1984, Dr. Denton A. Cooley performed the first pediatric heart transplant on a 9-month-old female patient. She lived to be 13 years old. Since that time, the heart transplant program has grown into one of the largest and most successful program of its kind in t...


More From BioPortfolio on "Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks